Clinical and research uses of genetic risk scores in type 1 diabetes. (June 2018)

• Record Type: Journal Article
• Authors: Sharp, Seth A; Weedon, Michael N; Hagopian, William A; Oram, Richard A
• Is Part Of: Current opinion in genetics & development. Volume 50(2018)
• Page Start: 96
• Page End: 102
• Publication Date: 2018-06
• Subjects: Genetics -- Periodicals; Developmental biology -- Periodicals; Developmental genetics -- Periodicals; 576.5
• DOI: 10.1016/j.gde.2018.03.009
• Languages: English
• ISSNs: 0959-437X

Abstract

Abstract : Type 1 diabetes (T1D) is a chronic disease of high blood glucose caused by autoimmune destruction of pancreatic beta cells eventually resulting in severe insulin deficiency. T1D has a significant heritable risk. Genetic associations found are particularly strong in the HLA class II region but T1D is a polygenic disease associated with over 60 loci across the genome. Polygenic risk scores are one method of summing these genetic risk elements as a single continuous variable. This review discusses the clinical and research utility of genetic risk scores in T1D particularly in disease prediction and progression. We also explore creative uses of genetic risk scores in big data and the limitations of using a genetic risk score. The increase in publically available genetic data and rapid fall in costs of genotyping mean that a T1D genetic risk score (T1D GRS) is likely to prove useful for disease prediction, discrimination, investigation of unusual cohorts, and investigation of biology in large datasets where genetic data are available.